CLINICAL_TRIALS
trial_result
· 2025-05-06
Clinical Trial Update: Ruxolitinib in Seborrheic Dermatitis [Phase 2]
Summary
Phase 2 trial evaluating ruxolitinib for seborrheic dermatitis has completed, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Seborrheic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2025-05-06